Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Report 2026
Download Free Sample Buy Now
Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Report 2026

Global Outlook – By Product Type (Diagnostic Kits, Therapeutic Kits, Combined Theranostic Kits), By Application (Prostate Cancer, Other Cancers), By End-User (Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

• Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market size has reached to $1.05 billion in 2025

• Expected to grow to $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%

• Growth Driver: Rising Incidence Of Prostate Cancer Fueling The Growth Of The Market Due To Aging Population And Increasing Disease Burden

• Market Trend: Advanced Diagnostic Kits Support Targeted Therapy And Treatment Planning

• North America was the largest region in 2025.

What Is Covered Under Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?

Prostate-specific membrane antigen (PSMA) theranostic kits are specialized tools for the detection and treatment of prostate cancer by targeting the PSMA protein highly expressed on cancer cells. They combine a PSMA-targeted imaging agent for accurate tumor localization with a therapeutic component that delivers treatment directly to cancer cells. These kits enable personalized medicine by improving cancer staging, monitoring treatment response, and minimizing damage to healthy tissue.

The main product types of prostate-specific membrane antigen (PSMA) theranostic kits are diagnostic kits, therapeutic kits, and combined theranostic kits. Diagnostic kits are tools that detect and visualize PSMA-expressing cancer cells using imaging agents, enabling accurate tumor localization, staging, and monitoring of prostate cancer. These find applications in prostate cancer, and others, serving end-users such as hospitals, diagnostic centers, research institutes, specialty clinics, and others.

Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Global Report 2026 Market Report bar graph

What Is The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size and Share 2026?

The prostate-specific membrane antigen (psma) theranostic kits market size has grown rapidly in recent years. It will grow from $1.05 billion in 2025 to $1.19 billion in 2026 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to rising incidence of prostate cancer, advancements in nuclear medicine imaging, increasing adoption of molecular diagnostics, early clinical validation of psma targeting, expansion of oncology research programs.

What Is The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Growth Forecast?

The prostate-specific membrane antigen (psma) theranostic kits market size is expected to see rapid growth in the next few years. It will grow to $1.99 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing demand for personalized cancer treatments, rising investments in theranostics, expansion of nuclear medicine infrastructure, growing use of precision oncology diagnostics, increasing regulatory approvals for targeted therapies. Major trends in the forecast period include increasing adoption of targeted radioligand therapies, rising use of psma-based precision diagnostics, growing integration of imaging and therapy workflows, expansion of personalized oncology treatment kits, enhanced focus on companion diagnostics.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Segmentation

1) By Product Type: Diagnostic Kits, Therapeutic Kits, Combined Theranostic Kits

2) By Application: Prostate Cancer, Other Cancers

3) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users

Subsegments:

1) By Diagnostic Kits: Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography Imaging Kits, Single Photon Emission Computed Tomography Imaging Kits, Companion Diagnostic Kits, Liquid Biopsy Kits

2) By Therapeutic Kits: Radioligand Therapy Kits, Antibody-Based Therapy Kits, Peptide-Based Therapy Kits, Small Molecule Therapy Kits

3) By Combined Theranostic Kits: Integrated Imaging And Therapy Kits, Dual Function Radiopharmaceutical Kits, Prostate-Specific Membrane Antigen (PSMA) Ligand-Based Theranostic Kits, Personalized Treatment Kits

What Is The Driver Of The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?

The rising incidence of prostate cancer is expected to propel the growth of the prostate-specific membrane antigen (PSMA) theranostic kits market going forward. Prostate cancer refers to a type of cancer that develops in the prostate gland, a small gland in men located below the bladder and in front of the rectum. The rising prevalence of prostate cancer is due to the aging population, as the risk of developing prostate cancer increases significantly with age. Prostate-specific membrane antigen (PSMA) theranostic kits enhance prostate cancer management by offering targeted diagnostic solutions, making them ideal for early detection and personalized treatment planning. They improve diagnostic accuracy by combining PSMA-specific ligands with radiotracers, supporting better disease monitoring and therapy guidance. For instance, in November 2023, according to the American Cancer Society, a US-based non-profit organization, approximately 313,780 new cases of prostate cancer and 35,770 deaths were estimated in the United States in 2025. Therefore, the rising incidence of prostate cancer is driving the growth of the prostate-specific membrane antigen (PSMA) theranostic kits industry.

Key Players In The Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

Major companies operating in the prostate-specific membrane antigen (psma) theranostic kits market are Cyclotek (Aust) Pty Ltd, Telix Pharmaceuticals Ltd, Curium Pharma, SOFIE Biosciences Inc., Lantheus Holdings Inc., Eckert & Ziegler SE, NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, AdvanCell Pty Ltd, Alpha-9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, RadioMedix Inc., Scintomics GmbH, Novartis AG, Bayer AG, POINT Biopharma Inc., Blue Earth Diagnostics

Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Trends and Insights

Major companies operating in the prostate-specific membrane antigen (PSMA) theranostic kits market are focusing on developing innovative solutions, such as PSMA-targeted radioligand kits, to meet the rising demand for precision oncology, targeted prostate cancer diagnosis, and therapy. PSMA-targeted radioligand kits are medical kits that combine a ligand specifically designed to bind to Prostate-Specific Membrane Antigen (PSMA) with a radioactive isotope for diagnostic imaging or targeted therapy of prostate cancer. For instance, in March 2025, Telix Pharmaceuticals Limited, an Australia-based radiopharmaceutical company, launched Illuccix, an innovative kit for the preparation of Gallium-68 gozetotide injection. This kit enables hospitals and nuclear medicine facilities to label the radionuclide immediately before injection for PET imaging of PSMA-positive prostate cancer lesions. The kit’s unique features include a ready-to-use preparation format, disease-specific targeting, rapid imaging capability, and compatibility with theranostic workflows, allowing better detection of metastatic lesions, treatment planning, and monitoring therapy response. Its applications include the diagnosis of recurrent or metastatic prostate cancer and guiding personalized treatment decisions, making it a significant advancement over conventional imaging or non-targeted therapies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?

In June 2023, Ariceum Therapeutics GmbH, a Germany-based biotech company, acquired Theragnostics Ltd. for an undisclosed amount. With this acquisition, Ariceum Therapeutics aims to enhance its technological capabilities in PSMA-targeted theranostic kits and expand its radiopharmaceutical portfolio in prostate cancer imaging. Theragnostics Ltd. is a UK-based biopharmaceutical company that develops PSMA-targeted diagnostic kits specifically 68Ga THP PSMA for prostate cancer imaging.

Regional Outlook

North America was the largest region in the prostate-specific membrane antigen (PSMA) theranostic kits market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?

The prostate-specific membrane antigen (PSMA) theranostic kits market consists of sales of radiolabeled therapeutic agents, diagnostic kits, combination theranostic kits, antibody-based PSMA theranostics, PSMA ligand-based drug conjugates, and companion diagnostic kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Report 2026?

The prostate-specific membrane antigen (psma) theranostic kits market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the prostate-specific membrane antigen (psma) theranostic kits industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.19 billion
Revenue Forecast In 2035 $1.99 billion
Growth Rate CAGR of 13.9% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Product Type, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Cyclotek (Aust) Pty Ltd, Telix Pharmaceuticals Ltd, Curium Pharma, SOFIE Biosciences Inc., Lantheus Holdings Inc., Eckert & Ziegler SE, NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, AdvanCell Pty Ltd, Alpha-9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, RadioMedix Inc., Scintomics GmbH, Novartis AG, Bayer AG, POINT Biopharma Inc., Blue Earth Diagnostics
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted Radioligand Therapies

4.2.2 Rising Use Of Psma-Based Precision Diagnostics

4.2.3 Growing Integration Of Imaging And Therapy Workflows

4.2.4 Expansion Of Personalized Oncology Treatment Kits

4.2.5 Enhanced Focus On Companion Diagnostics

5. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Centers

5.3 Research Institutes

5.4 Specialty Clinics

5.5 Nuclear Medicine Centers

6. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size, Comparisons And Growth Rate Analysis

7.3. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Segmentation

9.1. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Kits, Therapeutic Kits, Combined Theranostic Kits

9.2. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prostate Cancer, Other Cancers

9.3. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users

9.4. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography Imaging Kits, Single Photon Emission Computed Tomography Imaging Kits, Companion Diagnostic Kits, Liquid Biopsy Kits

9.5. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Therapeutic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radioligand Therapy Kits, Antibody-Based Therapy Kits, Peptide-Based Therapy Kits, Small Molecule Therapy Kits

9.6. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Combined Theranostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Integrated Imaging And Therapy Kits, Dual Function Radiopharmaceutical Kits, Prostate-Specific Membrane Antigen (PSMA) Ligand-Based Theranostic Kits, Personalized Treatment Kits

10. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Regional And Country Analysis

10.1. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

11.1. Asia-Pacific Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

12.1. China Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

13.1. India Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

14.1. Japan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

15.1. Australia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

16.1. Indonesia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

17.1. South Korea Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

18.1. Taiwan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

19.1. South East Asia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

20.1. Western Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

21.1. UK Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

22.1. Germany Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

23.1. France Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

24.1. Italy Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

25.1. Spain Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

26.1. Eastern Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

27.1. Russia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

28.1. North America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

29.1. USA Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

30.1. Canada Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

31.1. South America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

32.1. Brazil Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

33.1. Middle East Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

34.1. Africa Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Regulatory and Investment Landscape

36. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Competitive Landscape And Company Profiles

36.1. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Company Profiles

36.3.1. Cyclotek (Aust) Pty Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Telix Pharmaceuticals Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

36.3.4. SOFIE Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Other Major And Innovative Companies

Eckert & Ziegler SE, NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, AdvanCell Pty Ltd, Alpha-9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, RadioMedix Inc., Scintomics GmbH, Novartis AG, Bayer AG, POINT Biopharma Inc., Blue Earth Diagnostics

38. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

40. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market High Potential Countries, Segments and Strategies

40.1 Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market In 2030 - Countries Offering Most New Opportunities

40.2 Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market In 2030 - Segments Offering Most New Opportunities

40.3 Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Overview Of Key Products - Product Examples
  • Table 2: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Supply Chain Analysis
  • Table 4: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Raw Material Providers
  • Table 5: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Resource Providers
  • Table 6: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Manufacturers (Suppliers)
  • Table 7: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Distributors And Channel Partners
  • Table 8: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Key Technologies & Future Trends
  • Table 9: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Trends
  • Table 10: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major End Users
  • Table 11: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market - TAM, US$ Billion, 2025
  • Table 15: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Therapeutic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Combined Theranostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market - Company Scoring Matrix
  • Table 97: Cyclotek (Aust) Pty Ltd Financial Performance
  • Table 98: Telix Pharmaceuticals Ltd Financial Performance
  • Table 99: Curium Pharma Financial Performance
  • Table 100: SOFIE Biosciences Inc. Financial Performance
  • Table 101: Lantheus Holdings Inc. Financial Performance
  • Table 102: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Competitive Dashboard
  • Table 104: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Table 106: Global, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 107: Global, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

    Figure 1: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Supply Chain Analysis
  • Figure 4: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Raw Material Providers
  • Figure 5: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Resource Providers
  • Figure 6: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Distributors And Channel Partners
  • Figure 8: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Key Technologies & Future Trends
  • Figure 9: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major Trends
  • Figure 10: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Major End Users
  • Figure 11: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market - TAM, US$ Billion, 2025
  • Figure 15: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Therapeutic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Combined Theranostic Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market - Company Scoring Matrix
  • Figure 97: Cyclotek (Aust) Pty Ltd Financial Performance
  • Figure 98: Telix Pharmaceuticals Ltd Financial Performance
  • Figure 99: Curium Pharma Financial Performance
  • Figure 100: SOFIE Biosciences Inc. Financial Performance
  • Figure 101: Lantheus Holdings Inc. Financial Performance
  • Figure 102: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Competitive Dashboard
  • Figure 104: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030
  • Figure 106: Global, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 107: Global, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Prostate Specific Antigen (PSA) Test Market Report 2026 - Global Outlook – By Type (Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Type...

Prostate Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Instruments, Reagents And Consumables, Accessories), By Test Type (Preliminary Tests, Confirmatory Tests), By Prostate Cancer (Squamous Cell ...

Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026 - Global Outlook – By Type (Single Photon Emission Computed Tomography (SPECT), Photon Emission Computed Tomography (PET)), By Test Type (Preliminary Tests,...

Prostate Cancer Drugs Market Report 2026 - Global Outlook – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), B...

Drugs For Benign Prostatic hypertrophy Market Report 2026 - Global Outlook – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Other Types), By Distribution Channel (Hospital Pharmacies,...

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Report 2026 - Global Outlook – By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedur...

Carcinoembryonic Antigen Market Report 2026 - Global Outlook – By Test Method (Immunoassays, Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescent Immunoassay (CLIA), Electrochemiluminescence Immunoassay (ECLIA), R...

Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Market Report 2026 - Global Outlook – By Type (Urinary Incontinence Devices, Pelvic Organ Prolapse Devices), By Urinary Incontinence Devices (Artificial ...

Frequently Asked Questions

The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market was valued at $1.05 billion in 2025, increased to $1.19 billion in 2026, and is projected to reach $1.99 billion by 2030.

The global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market is expected to grow at a CAGR of 13.5% from 2026 to 2035 to reach $1.99 billion by 2035.

Some Key Players in the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market Include, Cyclotek (Aust) Pty Ltd, Telix Pharmaceuticals Ltd, Curium Pharma, SOFIE Biosciences Inc., Lantheus Holdings Inc., Eckert & Ziegler SE, NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, AdvanCell Pty Ltd, Alpha‑9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, RadioMedix Inc., Scintomics GmbH, Novartis AG, Bayer AG, POINT Biopharma Inc., Blue Earth Diagnostics .

Major trend in this market includes: Advanced Diagnostic Kits Support Targeted Therapy And Treatment Planning. For further insights on this market. request a sample here

North America was the largest region in the prostate-specific membrane antigen (PSMA) theranostic kits market in 2025. The regions covered in the prostate-specific membrane antigen (psma) theranostic kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us